| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.99 |
| 52 Week High | CN¥15.78 |
| 52 Week Low | CN¥4.61 |
| Beta | -0.031 |
| 1 Month Change | -20.18% |
| 3 Month Change | -23.03% |
| 1 Year Change | 33.17% |
| 3 Year Change | -42.31% |
| 5 Year Change | 8.56% |
| Change since IPO | 3.77% |
Recent News & Updates
Shareholder Returns
| 300313 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 2.6% | -2.7% | -2.7% |
| 1Y | 33.2% | -27.4% | -18.2% |
Return vs Industry: 300313 exceeded the CN Biotechs industry which returned -26.8% over the past year.
Return vs Market: 300313 exceeded the CN Market which returned -17.2% over the past year.
Price Volatility
| 300313 volatility | |
|---|---|
| 300313 Average Weekly Movement | 14.5% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 11.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300313's share price has been volatile over the past 3 months.
Volatility Over Time: 300313's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 107 | Jianjun Ge | www.xjtssw.com |
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in cattle and sheep breeding activities in China. The company engages in the improvement of cattle and sheep varieties, relying on biological genetic technology to provide embryo and other genetic materials and related services for the livestock industry.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. Fundamentals Summary
| 300313 fundamental statistics | |
|---|---|
| Market cap | CN¥2.50b |
| Earnings (TTM) | -CN¥22.00m |
| Revenue (TTM) | CN¥137.50m |
18.2x
P/S Ratio-113.7x
P/E RatioIs 300313 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300313 income statement (TTM) | |
|---|---|
| Revenue | CN¥137.50m |
| Cost of Revenue | CN¥114.14m |
| Gross Profit | CN¥23.36m |
| Other Expenses | CN¥45.36m |
| Earnings | -CN¥22.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 24, 2024
| Earnings per share (EPS) | -0.07 |
| Gross Margin | 16.99% |
| Net Profit Margin | -16.00% |
| Debt/Equity Ratio | 116.5% |
How did 300313 perform over the long term?
See historical performance and comparison